Items related to Clinically Relevant Resistance in Cancer Chemotherapy:...

Clinically Relevant Resistance in Cancer Chemotherapy: 112 (Cancer Treatment and Research, 112) - Hardcover

 
9781402072000: Clinically Relevant Resistance in Cancer Chemotherapy: 112 (Cancer Treatment and Research, 112)

Synopsis

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long­ term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

"synopsis" may belong to another edition of this title.

Synopsis

The present volume reviews clinically relevant aspects of the pharmacokinetics of commonly used anticancer agents as well as mechanisms of cellular/experimental resistance to such agents. This extends to technological advances that enable high-throughput studies of genetic polymorphisms, which has opened up new avenues to the study of drug resistance and to the individualization of chemotherapy in order to decrease clinical toxicity and optimize treatment results."This text provides a comprehensive review of the mechanisms of resistance to cancer chemotherapuetic agents. Leading experts discuss molecular and biochemical pathways that influence cytotoxicity. Knowledge of these potential obstacles to therapy will allow for the development of more effective strategies to treat malignant diseases." - Steven T. Rosen, M.D., Series Editor.

"About this title" may belong to another edition of this title.

Buy Used

Condition: Near Fine
380 pp. Tightly bound. Corners...
View this item

£ 36.51 shipping from U.S.A. to United Kingdom

Destination, rates & speeds

Other Popular Editions of the Same Title

9781461354284: Clinically Relevant Resistance in Cancer Chemotherapy: 112 (Cancer Treatment and Research, 112)

Featured Edition

ISBN 10:  1461354285 ISBN 13:  9781461354284
Publisher: Springer, 2012
Softcover

Search results for Clinically Relevant Resistance in Cancer Chemotherapy:...

Stock Image

Andersson, Borje; David Murraay, Eds
ISBN 10: 1402072007 ISBN 13: 9781402072000
Used Hardcover

Seller: Book Bear, West Brookfield, MA, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Cloth. Condition: Near Fine. 380 pp. Tightly bound. Corners not bumped. Boards show shelf rubbing / dulling. Text is Free of Markings. Seller Inventory # 005729

Contact seller

Buy Used

£ 4.46
Convert currency
Shipping: £ 36.51
From U.S.A. to United Kingdom
Destination, rates & speeds

Quantity: 1 available

Add to basket

Stock Image

Andersson, Borje.; Murray, David, eds.
Published by Kluwer Academic, Boston, 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
Used Hardcover

Seller: Tiber Books, Cockeysville, MD, U.S.A.

Seller rating 4 out of 5 stars 4-star rating, Learn more about seller ratings

Hardcover. Condition: Very Good. . . . . 8vo, hardcover. No dj. Vg condition. Prev. owner's name-labels very neatly removed from endpaper, contents bright, crisp & clean, unread. xx, 380 p. Seller Inventory # 1080501.15

Contact seller

Buy Used

£ 19.19
Convert currency
Shipping: £ 24.59
From U.S.A. to United Kingdom
Destination, rates & speeds

Quantity: 1 available

Add to basket

Stock Image

Published by Springer, 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Hardcover

Seller: Ria Christie Collections, Uxbridge, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. In. Seller Inventory # ria9781402072000_new

Contact seller

Buy New

£ 97.62
Convert currency
Shipping: FREE
Within United Kingdom
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

Andersson, Borje|Murray, David
Published by Springer US, 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Hardcover

Seller: moluna, Greven, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Gebunden. Condition: New. Seller Inventory # 4094907

Contact seller

Buy New

£ 82.35
Convert currency
Shipping: £ 21.65
From Germany to United Kingdom
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

David Murray
Published by Springer US, Springer US, 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Taschenbuch

Seller: AHA-BUCH GmbH, Einbeck, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The present volume reviews clinically relevant aspects of the pharmacokinetics of commonly used anticancer agents as well as mechanisms of cellular/experimental resistance to such agents. This extends to technological advances that enable high-throughput studies of genetic polymorphisms, which has opened up new avenues to the study of drug resistance and to the individualization of chemotherapy in order to decrease clinical toxicity and optimize treatment results.'This text provides a comprehensive review of the mechanisms of resistance to cancer chemotherapuetic agents. Leading experts discuss molecular and biochemical pathways that influence cytotoxicity. Knowledge of these potential obstacles to therapy will allow for the development of more effective strategies to treat malignant diseases.' Steven T. Rosen, M.D., Series Editor. Seller Inventory # 9781402072000

Contact seller

Buy New

£ 102.06
Convert currency
Shipping: £ 12.12
From Germany to United Kingdom
Destination, rates & speeds

Quantity: 1 available

Add to basket

Stock Image

Borje Andersson
Published by Springer-Verlag New York Inc., 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Hardcover
Print on Demand

Seller: THE SAINT BOOKSTORE, Southport, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 807. Seller Inventory # C9781402072000

Contact seller

Buy New

£ 114.47
Convert currency
Shipping: FREE
Within United Kingdom
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Stock Image

Andersson, Borje, M.D., Ph.D. (Editor)/ Murray, David (Editor)
Published by Kluwer Academic Pub, 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Hardcover

Seller: Revaluation Books, Exeter, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardcover. Condition: Brand New. 1st edition. 408 pages. 9.25x6.25x1.00 inches. In Stock. Seller Inventory # x-1402072007

Contact seller

Buy New

£ 109.47
Convert currency
Shipping: £ 6.99
Within United Kingdom
Destination, rates & speeds

Quantity: 2 available

Add to basket

Stock Image

0
Published by Springer, 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Hardcover

Seller: Basi6 International, Irving, TX, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEJUNE24-167627

Contact seller

Buy New

£ 117.57
Convert currency
Shipping: FREE
From U.S.A. to United Kingdom
Destination, rates & speeds

Quantity: 1 available

Add to basket

Stock Image

Published by Springer, 2002
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Hardcover

Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Seller Inventory # ABNR-83760

Contact seller

Buy New

£ 117.57
Convert currency
Shipping: FREE
From U.S.A. to United Kingdom
Destination, rates & speeds

Quantity: 1 available

Add to basket

Seller Image

David Murray
ISBN 10: 1402072007 ISBN 13: 9781402072000
New Taschenbuch
Print on Demand

Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as 'drug resistance'. This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 404 pp. Englisch. Seller Inventory # 9781402072000

Contact seller

Buy New

£ 95.49
Convert currency
Shipping: £ 30.33
From Germany to United Kingdom
Destination, rates & speeds

Quantity: 1 available

Add to basket

There are 2 more copies of this book

View all search results for this book